Drawing for MAGNA PURE

USPTO serial 79415332

MAGNA PURE

Reviewed by CopyMark Law Group

Reg. 8182174Status 700Registered
Filing date
Status date
Registration date
Mar 24, 2026
Examiner
MCPHERSON RAYBURN, SHAVELL A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MAGNA PURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mona Gupta

Mona Gupta Roche Diagnostics Operations, Inc.9115 Hague RoadIndianapolis, IN 46250United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for scientific purposes, other than for medical or veterinary use; diagnostic reagents for scientific or research use; chemicals for use in performing nucleic acid polymerase chain reactions, other than for medical and veterinary purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology research not for medical use; reagents in kit form comprising buffer solutions, DNA primers and nucleic acids for conducting enzyme-linked immunosorbent assays elisa, other than for medical or veterinary purposes; nucleic acid amplification reagents, for scientific and research use.ACTIVE—
005In vitro diagnostic preparations for medical use; diagnostic reagents for medical use; reagents for in-vitro laboratory use, for medical purposes; chemical preparations for medical purposes namely, for use in DNA analysis; nucleic acid sequences for medical and veterinary purposes.ACTIVE—
009Scientific apparatus and instruments for the purification of nucleic acids; scientific laboratory instruments, for DNA analysis, other than for medical use; scientific electric laboratory instruments for use in the diagnosis of blood for research purposes; quantitative polymerase chain reaction PCR instruments for scientific use; real-time polymerase chain reaction PCR instruments for scientific use; diagnostic apparatus for research laboratory use for detecting pathogens, DNA analysis; DNA microarrays; devices for analyzing protein sequence used as laboratory apparatus for scientific and research purposes; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; downloadable computer software for use in medical decision support systems; downloadable workflow management system software; downloadable bioinformatics software.ACTIVE—
010Genetic testing apparatus for medical purposes; diagnostic apparatus for medical purposes used in medical laboratories for testing DNA; real-time polymerase chain reaction PCR medical instruments for medical use; medical diagnostic testing instruments for use in immunoassay procedure; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels for medical use; apparatus for DNA and RNA testing for medical purposes; medical diagnostic apparatus for analzying DNA, RNA, and viral nucleic acids medical purposes.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 17, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 1, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 1, 2026FIMPFINAL DISPOSITION PROCESSED—
Jul 9, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 24, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 22, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 22, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 24, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 24, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 3, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 3, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 28, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 12, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 9, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 9, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 9, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2025RFNTREFUSAL PROCESSED BY IB—
May 10, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 10, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 23, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 22, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2025DOCKASSIGNED TO EXAMINER—
Feb 7, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 7, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 7, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 7, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 29, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 29, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 23, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance